Bioluminescent Imaging of Trypanosoma brucei Shows Preferential Testis Dissemination Which May Hamper Drug Efficacy in Sleeping Sickness by Claes, Filip et al.
Bioluminescent Imaging of Trypanosoma brucei Shows
Preferential Testis Dissemination Which May Hamper
Drug Efficacy in Sleeping Sickness
Filip Claes
1,2*, Suman K. Vodnala





4, Bruno Maria Goddeeris
2, Philippe Bu ¨scher
1, Martin E. Rottenberg
3
1Institute of Tropical Medicine Antwerp, Department of Parasitology, Antwerp, Belgium, 2Katholieke Universiteit Leuven, Deptartment of Biosystems, Leuven, Belgium,
3Karolinska Institute, Microbiology and Tumorbiology Center, Stockholm, Sweden, 4Laboratoire de Microbiologie Cellulaire et Mole ´culaire et Pathoge ´nicite ´ UMR/CNRS-
5234, Universite ´ Victor Segalen Bordeaux II, Bordeaux, France
Abstract
Monitoring Trypanosoma spread using real-time imaging in vivo provides a fast method to evaluate parasite distribution
especially in immunoprivileged locations. Here, we generated monomorphic and pleomorphic recombinant Trypanosoma
brucei expressing the Renilla luciferase. In vitro luciferase activity measurements confirmed the uptake of the coelenterazine
substrate by live parasites and light emission. We further validated the use of Renilla luciferase-tagged trypanosomes for
real-time bioluminescent in vivo analysis. Interestingly, a preferential testis tropism was observed with both the
monomorphic and pleomorphic recombinants. This is of importance when considering trypanocidal drug development,
since parasites might be protected from many drugs by the blood-testis barrier. This hypothesis was supported by our final
study of the efficacy of treatment with trypanocidal drugs in T. brucei-infected mice. We showed that parasites located in
the testis, as compared to those located in the abdominal cavity, were not readily cleared by the drugs.
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Introduction
Human and animal African trypanosomoses are important
protozoan infections endemic in Africa, Latin America and Asia,
caused by several species such as Trypanosoma brucei, T. evansi, T.
equiperdum, T. congolense and T. vivax. Different species, strains within
the species and clones within various strains show different tissue
tropism that may further vary within hosts [1]. Currently no vaccines
against human and animal trypanosomoses are available; and a
limited range of drugs exist to treat these diseases. Moreover, most of
the drugs used in second stage sleeping sickness show a high toxicity
while in animal trypanosomosis drug resistance becomes more and
more problematic [2]. Our current knowledge on tissue tropism,
mechanisms by which trypanosomes invade and spread into tissues,
the temporal course of invasion and the drug accessibility to
trypanosomes in tissues, is incomplete. To complement classical
anatomopathological examinations, real-time biophotonic imaging
seems straight forward. Bioluminescence in vivo imaging allows
longitudinal monitoring of an infection in the same animal, a
desirable alternative to analyzing a number of animals at many time
points during the course of the infection. To date, most biolumines-
cence models have been generated to monitor pathogenic bacterial
infections, such as Salmonella, and bacterial meningitis [3,4]. Among
pathogenic protozoa only Plasmodium berghei, Leishmania amazonensis
and Toxoplasma gondii have been engineered to express the firefly
luciferase and used in bioluminescence imaging [5–7]. To our
knowledge, no bioluminescent model for trypanosomes has been
developed. Here we report the generation of recombinant Renilla
luciferase expressing parasites, and the validation of the use of a real time
biophotonic detection of parasites to study the dissemination of
African trypanosomes in mice in vivo and the efficiency of treatment
with trypanocidal drugs in vitro and in vivo.
Materials and Methods
Construction of luminescent T. brucei, transfections and
cell culture
The Rluc gene was PCR-amplified from pGL4.70 (Promega)
and cloned into the pHD309 plasmid [8] using the In-Fusion PCR
cloning kit (ClonTech). Plasmids were screened via HindIII/
BamHI double restriction-digestion, sequenced, and those with the
correct insert in frame were selected and propagated in E. coli. Ten
mg of the Rluc-pHD309 plasmid was linearized using NotI (10 U,
3 hours at 37 C). T. brucei bloodstream forms (Lister 427 host cell
line 90-13 and AnTat 1.1
E) were cultured at 37uC, 5% CO2 in
IMDM medium (Gibco) supplemented with 10% (v/v) heat-
inactivated fetal calf serum, 36 mM sodium bicarbonate,
136 mg.ml
21 hypoxanthine, 39 mg.ml
21 thymidine, 110 mg.ml
21
NaPyruvate, 28 mg.ml
21 bathocuproine, 0.25 mM b-mercapto-
ethanol, 2 mM L-cystein and 62.5 mg.ml
21 kanamycin [9]. A
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7 parasites was resuspended in 400 ml warm cytomix
(2 mM EGTA, 120 mM KCL, 0.15 mM CaCl2,1 0 m M
K2HPO4/KH2PO4 pH 7.6, 25 mM Hepes, 0.5%Glucose,
1 mM Hypoxanthine, 100 mg/ml BSA, 5 mM MgCL2) [10] and
transferred into a 4 mm cuvette; 10 mg of linearized DNA
construct was added and left for one minute at 37uC. Subsequently
the mixture was pulsed once in a Gene Pulse Xcell square wave
electroporator at 1250 V, 25 Ohm, 50 mF and transfected cells
were added to 12 ml of preheated IMDM, plated in a 24-well
plate (24-time 500 ml) and incubated at 37uC for 24 h. Next,
500 ml of preheated IMDM containing 10 mg/ml hygromycin
were added to obtain a final selection concentration of 5 mg/ml.
Positive clones were evident at 6 days post transfection.
Immunofluorescence and microscopy
Transfected Trypanosoma brucei brucei AnTat 1.1
E bloodstream
form trypanosomes were grown for 3 days in mice. Ten microlitres
of blood were spread over a microscope slide and fixed with acetone
for 15 minutes. The fixed cells were incubated at room temperature
with primary and secondary antibodies for 1 h and 30 min,
respectively, and washed two times for 5 min with PBS after each
of the incubations. The primary antibody, monoclonal mouse anti-
Renilla luciferase (Millipore), was diluted 1:2 in PBS. The secondary
antibody, fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse (Jackson), was diluted 1:100 in a solution of 0.1 mg.ml
21
Evans Blue and 1 mg.ml
21 DAPI in PBS. Cells were analyzed on an
Olympus BX-41 UV microscope, and images were captured by a
Colorview II camera (Soft Imaging Systems) and Cell_D software
(Soft Imaging Systems) was used for analysis.
In vitro bioluminescence measuring
The Renilla Luciferase Assay System (Promega) was used to
measure in vitro luciferase activity. Non-transformed T. brucei Lister
427 and T. brucei 427–Rluc-pHD309 clones were grown up to a total
of 1610
7 parasites (10 ml of 1610
6 cells/ml), spun down at 1500 g
for 10 minutes, resuspended in 20 mlI M D Mm e d i u ma n d
subsequently added to 100 mlo fRenilla Luciferase Assay (1 mlo f
1006RenillaLuciferaseAssaysubstratedissolvedinto100 mlo fRenilla
Luciferase Assay Buffer). The level of Renilla luciferase activity (RLU)
from 1610
6 samples was monitored at different time points after
substrate addition in a luminometer. To monitor the signal of lysed
cells, the same amount of cells was lysed and measured in the same
system according to manufacturers instructions.
In vivo bioluminescence imaging
Mice were anaesthetized with 2.3% isoflurane. At different days
after infection, mice were injected intraperitoneally with 100 mLo f
coelenterazine (2 mg/ml dissolved in methanol) (Synchem) diluted




recorded in an IVIS Imaging System 100 (Xenogen LifeSciences)
and Living ImageH 2.20.1 software (Xenogen) for 180 seconds.
Measurements started 3–5 minutes after substrate injection to
allow the spread of the coelenterazine.
Immunohistochemistry
Mice at 25 days after infection were deeply anaesthetized with
isoflurane, sacrificed and testes were dissected. To examine
presence of trypanosomes within and outside blood vessels in the
testis, sections were cut, mounted, fixed and immunostained with
anti-AnTat 1.1 VSG (1:5.000) and goat polyclonal anti-glucose
transporter 1 (1:40; GLUT-1, Santa Cruz Biotechnology, Santa
Cruz, CA, USA) as described previously [11]. Glut 1 usually used
to stain cerebral blood vessels has also been shown to be expressed
by testicular endothelial cells [12]. Sections were examined and
analysed using a Nikon fluorescence microscope. Photomicro-
graphs were taken with a Zeiss AxioCam digital camera.
Parasite viability by oxidation to formazan
WST-1(tetrazolium salt) salts are cleaved to formazan by cellular
oxidoreductases. The augmentation in enzyme activity lead to an
increase in the amount of formazan dye formed. The viable cells
were quantified by the formazan dye produced by metabolically
active cells. To measure the drug sensitivity of cordycepin and other
drugs, 25000 parasites were cultured in 100 ml in vitro in a 96 well
culture plate with serial drug dilutions. Viability of the parasites was
measured by adding 10 ml of WST reagent and further incubation
for 2 hours. Readings were taken by a multiwell scanning
spectrophotometer at excitation wavelength of 450 nm.
CFSE assay
In order to measure single cell proliferation trypanosomes at
different days of culture CFSE labeling was performed as
described for mammalian cells [13]. To each milliliter of cell
suspension, 2 ml of carboxyfluorescein diacetate, succinimidyl ester
or CFDA-SE (CFSE) 5 mM stock solution was added and
immediately mixed to ensure uniform staining, resulting in a final
concentration of 10 mM CFSE. The cells were incubated 15 min
at 37 C and the cells were quenched by adding 5 volumes of
culture medium. Cells were analysed by flow cytometry with
logarithmic detection of green fluorescence.
Animal welfare and ethics
All mice were housed in filter-top cages and maintained in SPF
barrier facilities in individual ventilated cages at the Karolinska
Institute, Stockholm, or at the Institute for Tropical Medicine
Antwerp. Animal ethics approval for the infection of live animals
with recombinant trypanosomes was obtained from the respective
Animal Ethical Committees of the Karolinska Institute (Sweden)
and the Institute of Tropical Medicine, Antwerp (Belgium).
Results
Construction of luminescent T. brucei, expression and
localisation of Renilla luciferase in the parasite
For stable transfection of Renilla luciferase (Rluc) into the b-tubulin
region of the bloodstream formof monomorphic Tb .b r u c e iLister 427
Author Summary
Human African trypanosomiasis or sleeping sickness,
caused by two subspecies of Trypanosoma brucei,i s
endemic in Subsaharan Africa. There is no vaccine and the
currently used drugs are toxic and can cause severe side
effects and even death. At present, we do not know how
and when parasites can leave the blood and penetrate into
organs (especially the brain). Such knowledge will be very
helpfultodevelopand validate newdrugsthatcanclearthe
parasite from both the blood and the tissues. In this study,
we developed a novel technique allowing us to track the
parasites in a live animal by the use of light signals. By
following the luminescent parasites in the mouse we
showed that, interestingly, the organisms migrate very
early in infection to the testes. Here, they may be protected
from the immune system and from drugs. Indeed when
treating the mice with a sub-optimal dose of medicine, the
parasites in this location were not cleared and subsequently
could cause a reinvasion into the blood of the host.
Trypanosome Testis Tropism
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amplified and cloned into the pHD309 plasmid [8]. Plasmids were
screened via HindIII/BamHI double restriction-digestion, se-
quenced, and those with the correct insert in frame were selected
and propagated in E. coli.F o rt r a n s f e c t i o n ,2 610
7 parasites were
electroporated with NotI linearized DNA construct in a BioRad
Gene Pulse Xcell square wave electroporator. Two independent
transfections were performed and three clones from each population
were selected for further luminescence experiments
In vitro bioluminescence, uptake of substrate and light
emission of live cells
The kinetics of luciferase activity of T. brucei Lister 427 and
AnTat 1:1 clones showed a fast reaction and prolonged response
during time. Both live and lysed cells showed a high relative
luciferase units (RLU) activity, although the RLU signals for lysed
cells were about 5 to 10 times higher (Figure 1A and data not
shown). A linear relationship between concentration of live
parasites and the RLU could be observed (Figure 1B). The Renilla
Luciferase Assay System (Promega) was used to measure in vitro
luciferase activity of live and lysed parasites.
Subsequently, we verified whether the RLU signal measured from
live cells was due to substrate uptake and not residual activity of free
luciferase released from damaged or live cells during manipulation.
First, cells were spun down, the supernatants collected and the cell
pellet resuspended and luciferase activity measured in supernatants
and cell pellets. Over70% of the original light emissionwasgenerated
by the cell pellet whereas a negligible signal was detected in the
supernatant (data not shown). As a second control, FACS analysis
performed on 10
6 non-lysed parasites incubated with propidium
iodide, a marker for non-viable cells, showed no incorporation of the
dye, indicating that over 99% of the cells were intact after
manipulations (data not shown). Taken together, these results suggest
that the luciferase substrate coelenterazine penetrates or is taken up
by live trypanosomes and that the detected luciferase is not secreted
or released by the trypanosomes.
Renilla luciferase was expected to locate in the cytoplasm. Indeed,
luciferase was immunostained throughout the whole cell with a
slightly higher concentration around the flagellum (Figure 1C).
We then investigated if coelenterazine is toxic for parasites since
this could hamper the follow up of the infection in vivo. Parasites
were grown in vitro in the presence of different concentrations of
coelenterazine and parasite growth was measured during
72 hours. Coelerenterazine at concentrations required for in vivo
usage did not inhibit parasite proliferation (Figure 1D).
T. brucei undergoes a life cycle stage differentiation from a long
slender to a short stumpy form [14]). We analysed whether slender
and stumpy forms of T. brucei express luciferase activity and cleave
WST-1. Parasites were alive in our culture condition until day 4–5
of culture. Exponential growth of parasites was observed during
the first 48 h in cultures whereas at day 3–4 similar parasite
concentrations were observed. Confirming previous data [14], the
lack of increase in parasite density in the cultures was due to an
arrest in proliferation rather than to an increased parasite death, as
visualized by the dilution of CFSE by parasites during the days 1
and 2 but not 3 and 4 of culture (Figure 1 E). Long slender had
lower WST-1 cleavage ability per cell than stumpy forms (Figure 1
G), whereas stumpy forms showed negligible luciferase activity
compared to long slender forms (Figure 1 F).
In vivo bioluminescence, model validation and tropisms
observed
The outcome of infection with the monomorphic T. brucei Lister
427 in female mice was then studied. Mice infected i.p. with 10,
100 or 1000 parasites were inoculated i.p. with 20 mg/kg
coelenterazine 2–4 minutes before light measurement. All mice
died 5 days after infection with 1000 T. b. brucei, while when
inoculated with 10 or 100 parasites mice survived up to day 11
after infection (Figure 2A). A fraction of mice survived that
inoculation. With exception of one animal, none of the surviving
animals showed detectable parasitemia. Light emission, usually
located in the peritoneal cavity, was observed in all mice showing
positive parasitemia (Figure 2A).
The inoculation of BALB/c male mice with 2.10
4 pleomorphic
luciferase tagged T. b. brucei AnTat 1.1E resulted in a prolonged
survival, similar to that observed after infection with the isogenic
non-recombinant parasites (data not shown). Mice showed signs of
morbidity circa 3 weeks after infection but no increased light
emission or parasitemia. The intensity of light emission was not
always associated with parasitemia levels. Interestingly, a prefer-
ential localization of parasites in the testis was detected in several
animals infected with T. b. brucei AnTat 1.1
E (Figure 2B), an
observation that was reproduced when infecting male BALB/c
mice with T. brucei Lister 427 (data not shown). When performing
bioluminescence experiments in female mice, no apparent
sequestration to the sexual organs (in casu the ovaries) was
observed (data not shown). We studied if the pressure exerted by
the adaptive immune responses determined preferential localiza-
tion in the testis. For this purpose we infected B- and T cell-
deficient RAG1
2/2 mice with 100 T. b. brucei Lister 427
recombinant parasites. RAG1
2/2 mice also showed testis
localization of T. b. brucei after infection indicating that testis
localization is probably due to parasite tropism for testis or
enhanced parasite growth in this organ (Figure 3A).
The immunostaining of trypanosomes in the testis of mice 25
days after infection with T. b. brucei AnTat 1.1
E confirmed the
information provided by the bioluminescent technique. Trypano-
somes were observed within and outside blood vessels, in the
interstitial stroma between seminiferous tubules (Figure 3B).
In the experiments described above, biophotonic emission could
be mainly detected in the abdominal cavity, and less frequently in
the thorax and head of infected animals. Whether such
localization was due to a preferential dissemination of the parasite
in the abdomen and pelvis or to a non-homogenous distribution of
coelenterazine in vivo was investigated. To analyze these possibil-
ities mice infected with T. b. brucei AnTat 1.1
E were sacrificed and
light production measured in organs after incubation with the
substrate ex-vivo. Light was detected in the brain, spleen, lung and
testis and to a lesser extent in the liver of infected mice. No light
emission was detected in uninfected control animals (Figure 4A).
Thus, a non-homogeneous distribution of coelenterazine after
inoculation probably accounted for the light production pattern
observed in vivo. Hence, we compared the light production after
intraperitoneal (ip) and intravenous (iv) inoculation of coelenter-
azine into mice infected with T. b. brucei AnTat 1.1
E. While an
abdominal localization of light emission was detected in mice
inoculated i.p. (Figure 4B) with coelenterazine, the iv inoculation
of the substrate resulted in a thorax and cranial localization,
suggesting an incomplete body distribution of the substrate by
either route (Figure 4C).
Application of the bioluminescent model: In vitro and in
vivo drug efficacy testing
Whether recombinant parasites could be used for testing the
efficiency of trypanocidal compounds in vitro was then studied.
Light detection and parasite viability at different time points after
incubation with the trypanocidal adenosine analogue cordycepin
showed similar kinetics (Figure 5A, B). Parasites were also
Trypanosome Testis Tropism
www.plosntds.org 3 July 2009 | Volume 3 | Issue 7 | e486Figure 1. In vitro bioluminescence, uptake of substrate and light emission of live cells. A. In vitro activity of 6 clones of T.b. brucei 427-Rluc
expressing the Renilla luciferase is shown at different time points after substrate addition. Clones 1–3 and 4–6 were selected from two independent
electroporation events. Efficiency of Renilla luciferase expression in clones 1–3 is lower than clones 4–6, yet resulting in a detectable signal. Clone 4
was selected for further in vivo work, showing a high RLU signal slowly decreasing over time. Negative control corresponds to non-transformed T.b.
brucei 427. B. Correlation between parasite concentration and RLU activity. Different concentrations of Rluc transfected T.b. brucei Lister 427 were
incubated with coelenterazine and RLU of triplicate wells measured after 5 minutes incubation. C. Expression and localization of Renilla luciferase in T.
brucei AnTat 1.1E. Anti-Renilla FITC staining (left), DAPI staining (middle) and overlay (right). Magnification: 606.D .T.b. brucei Lister 427 was incubated
for 72 h with different concentrations of coelenterazine and the viability of triplicate cultures of the parasites was determined by WST-1 assay in
relation to untreated parasites. The arrow indicates the final concentration of coelenterazine used in vivo. E. Luciferase activity in different life stages
of T. b. brucei AnTat1.1
E. Parasites were labeled with CFSE at 0 or 48 h after initiation of the culture. At 0 or 48 h after labeling cells parasites were
fixed and CFSE dilution in daughter cells was analysed by FACS. F, G. T. b. brucei AnTat1.1
E density, WST-1 assay and RLU were measured in triplicate




www.plosntds.org 4 July 2009 | Volume 3 | Issue 7 | e486Figure 2. In vivo bioluminescence models. A. Dynamics of T.b. brucei Lister 427 infection in female BALB/c mice. Balb/c mice were infected i.p.
with the indicated numbers of T.b. brucei lister 427. Coelenterazine was inoculated 3–5 minutes before light detection in an IVIS Imaging System. This
procedure was repeated at different days after infection. A non infected mouse is included as a control on the left of each image set. Color scales
indicate photon emission (photons s21c m 22) during a 180-s exposure. The parasitemia levels of individual mice at the specific time points are also
indicated (610
6/ml). B. Dynamics of T.b. brucei AnTat 1.1 infection visualized by bioluminescence imaging. Parasite load in BALB/c male mice injected
i.p. with 2610
4 luciferase recombinant T.b. brucei AnTat 1.1 was assessed daily by biophotonic emission determination as indicated in material and
methods. Parasitemia levels were registered in parallel (610
6/ml).
doi:10.1371/journal.pntd.0000486.g002
Figure 3. Testis localization of bioluminescent T. b. brucei. A. RAG1
2/2 mice at 0 (left) and 7 days after infection (right) with 2610
4 T. brucei
Lister 427 were inoculated with coelenterazine and biophotonic emission was assessed. B. Immunostaining of trypanosomes and endothelial cells in
sections of testis from mice 25 days after infection with 2610
4 T.b. brucei Antat 1.1E i.p. Numerous parasites (in red) are observed in the blood vessels
and in the interstitial tissue between the seminiferous tubules. Magnification: 2506.
doi:10.1371/journal.pntd.0000486.g003
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luciferase activity and parasite viability were equally diminished at
similar concentrations of cordycepin (Figure 5C).
Subsequently, the luciferase-labeled parasites were used to
validate the biophotonic method for testing of trypanocidal
compounds in vivo. Treatment with 7 doses of cordycepin and
the adenosine deaminase inhibitor deoxycoformycin cures exper-
imental infections with T. b. brucei [15]. A sub-curative treatment
with cordycepin and deoxycoformycin in RAG1
2/2 mice infected
with luciferase tagged strains resulted in waning of biophotonic
emission (Figure 5D). Several days after treatment, light
production and parasitemia were detectable. Some mice showed
light production in testis suggesting that T. brucei are protected by
the testis-blood barrier from suboptimal doses of trypanocidal
drugs (Figure 5D). In contrast, neither parasitemia or light
emission were detected in luciferase-tagged T. b. brucei infected
BALB/c mice treated daily for 7 days with cordycepin and
deoxycoformycin starting 5 days after infection (Figure 6).
Discussion
In this paper, we demonstrate for the first time the feasibility of
detecting live trypanosomes through real-time in vivo and ex vivo
luminescence imaging. We opted to use Renilla luciferase rather
than firefly luciferase since previous studies in procyclic trypano-
somes (insect stage) showed that the firefly luciferase accumulated
in glycosomes [16]. This may impede the growth of bloodstream
mammalian forms due to major changes in the energy metabolism
and thereby hamper in vivo bioluminescence studies (George Cross,
personal communication). There may be two reasons why the
Renilla luciferase worked so well in vivo (i) the substrate
coelenterazine is less polar than d-luciferin, and might pass
through the cell membranes more readily and (ii) the C-terminus
of Renilla luciferase (VLKNEQ) does not appear to have a
peroxisomal targeting sequence, whereas firefly has the classic
GGKSKL. Hence, we showed that Renilla luciferase was located in
the cytoplasm where the substrate accumulates and does not
hamper energy metabolism in the glycosome. A dose of 20 mg
coelenterazine was used as a substrate, as described previously for
the monitoring of metastasis in mice using bioluminescence [17].
Of importance is the stage-dependent luciferase activity, being
significantly lower in stumpy than in slender forms. The transition
of slender into stumpy bloodstream forms includes cell cycle arrest
and a decrease in protein synthesis, probably due to decrease
polysome formation [18] that could account for lower luciferase
activity in this life stage. On the contrary, the stumpy forms
showed increased WST-1 reduction probably attributed to the
increased levels of oxidoreductases in this form compared to long
slender forms [19].
Analogous to other models [20], live T. b. brucei produced light
after addition of substrate and distinct temporal differences in light
production were revealed following intravenous or intraperitoneal
delivery. Bhaumik and Gambhir [21] stated in their discussion that
biodistribution of coelenterazine and the potential toxicity of
repetitively using coelenterazine in living mice should be further
investigated. They hypothesized that is was likely that coelenter-
azine will be accessible to many tissues because of its diffusible
nature. We found that repeated injection of coelenterazine did not
show toxic effects on the mice. However, the distribution of
coelenterazine in vivo seemed not homogenous and depended
largely on the way of administering the substrate. This is in
accordance with recent findings [22] which showed that intranasal
administration of luciferin rather than intraperitoneal injection
increased the sensitivity of detecting nasal and pulmonary airway
infections by a 30-fold. Hence the route of substrate administration
should be considered in the interpretation of the real time images.
According to the tissues of interest, either intraperitoneal,
intravenous, or a dual injection, should be considered. Another
possibility would be to increase the dose of substrate to verify if the
local tissue concentration of coelenterazine is sufficient to give a
detectable signal. According to the toxicity assays (Figure 1D) it
would be possible to increase the dose by a 10-fold.
The lack of toxicity of coelenterazine for parasites and the host at
the doses used in vivo, and the lack of light emission by killed
recombinant parasites support the strength of luciferase-tagged
parasites to study in vivo parasite dissemination as well as drug
compound screening, both in vitro and in vivo. The Rluc-pHD309
plasmid integrates at the conserved b-tubulin of the Trypanosoma
species,henceother T.brucei strains and taxa can easily be transfected
with the Renilla luciferase marker resulting in new models to monitor
drug sensitivity and the spread of parasites in a murine model.
Figure 4. The light production in organs and after intraperitoneal (ip) and intravenous (iv) substrate inoculation. A. Imaging of
bioluminescent parasites in organs from BALB/c mice infected i.p. with 2610
4 T.b. brucei AnTat 1.1 and uninfected controls 20 days after infection.
Coelenterazine was added to all organs before light detection ex vivo. B, C. Real time in vivo imaging of light producing T.b. brucei AnTat 1.1 in mice at
day 20 after infection. Coelenterazine was inoculated i.v. (B) or i.p. (C) 2–4 minutes before light detection.
doi:10.1371/journal.pntd.0000486.g004
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www.plosntds.org 6 July 2009 | Volume 3 | Issue 7 | e486Figure 5. A sub-curative treatment with cordycepin and deoxycoformycin shows light emission in the testis. A, B. Parasites (10
6 per ml)
were incubated with 2 mM cordycepin or medium. The light production (A) or the viability as determined by a WST-1 assay (B) measured in triplicate
cultures at different time points (in hours) after incubation. Results are expressed as fraction of the controls determined at 0 h of incubation. C. T.b.
brucei Lister 427 (2610
4 cells) were incubated with different concentrations of cordycepin. The RLU and the parasite viability were determined 72 h
after incubation. Results are expressed as fraction of each parameter in relation to the untreated controls. D. Kinetics of infection of RAG1
2/2 male
mice with recombinant T.b. brucei Lister 427. RAG1
2/2 mice were infected ip with 100 T.b. brucei Lister 427. Five days after infection mice were treated
i.p. with 2 mg/kg cordycepin daily for 3 days. Parasite load was measured by bioluminescence imaging and parasitemia was registered.
doi:10.1371/journal.pntd.0000486.g005
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www.plosntds.org 7 July 2009 | Volume 3 | Issue 7 | e486Figure 6. Curative treatments with cordycepin and deoxycoformycin shows disappearing light signals. Kinetics of infection of BALB/c
male mice with recombinant T.b. brucei Lister 427. BALB/c mice were infected ip with 100 T.b. brucei Lister 427. Five days after infection mice were
treated i.p. with 2 mg/kg cordycepin daily for 7 days. Parasite load was measured by bioluminescence imaging and parasitemia was registered.
doi:10.1371/journal.pntd.0000486.g006
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testis. T. b. brucei parasites could be observed extravascularly in
testis but not in the seminiferous duct, suggesting sexual
transmission is unlikely. Accordingly, we observed that no female
immunodeficient mice became infected when mated with T. brucei-
infected BALB/c mice. Of interest, the natural transmission of
Trypanosoma equiperdum closely related to T. brucei, occurs during
copulation [23]. The distribution of trypanosomes in the testicular
tissue is in accordance with a previous study showing that
trypanosomes were present in the intertubular tissues, but never
crossed the basal lamina of seminiferous tubules [24]. In that
study, necrosis of cells in the seminiferous tubule and a
mononuclear infiltration in the interstitium was noted. It might
be that in T. equiperdum infections in equines this may contribute to
disease transmission. Biophotonic real time detection of parasite
dissemination will be useful to study T. equiperdum models to
examine tissue tropisms and transmission routes.
We should note that the current model uses intraperitoneal
injection which may somehow bias the observed dissemination of
the parasites. In future models it may be interesting to perform
subcutaneous infections which mimic tsetse delivery.
The possibility that parasites have a preferential tropism for
testes can also be of importance when considering drug
development, since parasites might be protected from many drugs
by the blood-testis barrier. In line with this, parasites were detected
in testes upon reactivation of the infection in mice treated with
sub-curative doses of cordycepin and deoxycoformycin.
It could be further speculated that the proximity of parasites to
Leydig cells located in the interstitial tissues might affect the
endocrine balance, contributing both to the pathology of disease.
In line with this idea, testosterone levels, testicular responsiveness
to exogenous gonadotropin and number of testicular LH receptors
were reduced in T. b. brucei infected rats indicating gonadal
imbalance [25]. Decreased concentrations of testosterone were
detected in patients with human African trypanosomiasis [26]. In
accordance, we observed that no offspring was generated after
mating 4 male mice 20 days after infection with T. brucei
AnTat1.1E with 2 uninfected females each for 10 days. All
females remained uninfected, suggesting male sterility and absence
of sexual transmission of the parasites. The preference of parasites
for the testes does not appear to be a result of immune pressure
since it also occurred in RAG1
2/2 mice, lacking B and T cells.
In conclusion, this bioluminescent model opens new avenues to
examine the dissemination of parasites of different Trypanosoma
species into different organs, and the in vivo monitoring of drug
efficiency.
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